Impaired Brain Growth in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Acute Disseminated Encephalomyelitis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 4, 2022
- Accepted in final form October 10, 2022
- First Published February 8, 2023.
Author Disclosures
- Frederik Bartels, MD*,
- Birgit Baumgartner, MD*,
- Annette Aigner, PhD*,
- Graham Cooper, PhD,
- Astrid Blaschek, MD, PD,
- Eva Maria Wendel, MD,
- Annikki Bertolini, MD,
- Michael Karenfort, MD,
- Matthias Baumann, MD,
- Robert Cleaveland, MD,
- Andreas Wegener-Panzer, MD,
- Steffen Leiz, MD,
- Michela Salandin, MD,
- Peter Krieg, MD,
- Tobias Reindl, MD,
- Markus Reindl, PhD†,
- Carsten Finke, MD† and
- Kevin Rostásy, MD†
- Frederik Bartels, MD*,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Frederik Bartels is participant in the BIH-Charité Clinician Scientist Program funded by the Charité – Universitätsmedizin Berlin and the Berlin Institute of Health.
None
NONE
NONE
NONE
NONE
NONE
NONE
- Birgit Baumgartner, MD*,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Annette Aigner, PhD*,
None
NONE
Commercial, CENTOGENE - The Rare Disease Company, personal fees for workshop introductory statistics
NONE
NONE
NONE
NONE
Commercial, Work as Statistical Reviewer for Journal ofCerebral Blood Flow and Metabolism (JCBF)
NONE
(1) Non-profit, Teaching at Hamburg University ofApplied Sciences (HAW), Germany (2) Non-profit, Teaching at Bernhard-Nocht-Institute, Germany
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Graham Cooper, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Astrid Blaschek, MD, PD,
(1) Novartis
NONE
(1) Roche travel payment
European J of Pediatric Neurology, editorial Board , since 2015
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Eva Maria Wendel, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Annikki Bertolini, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Michael Karenfort, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Matthias Baumann, MD,
(1) Novartis (2)Biogen (3) Sanofi (4) Roche (5) Pfizer (6) Merz
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Robert Cleaveland, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Andreas Wegener-Panzer, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Steffen Leiz, MD,
None
NONE
(1)Desitin Arzneimittel GmbH, speaker honoraria(2)Zogenix, speaker honoraria(3)Eisai, speaker honoraria
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Michela Salandin, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Peter Krieg, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Tobias Reindl, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Markus Reindl, PhD†,
None
NONE
None
PLOS ONE, academic editor, 2012-2020
NONE
NONE
NONE
NONE
NONE
The University Hospital and Medical University of Innsbruck (Austria, employer of M.R.) receive payments for antibody assays (NMDAR, AQP4 and other autoantibodies) and for MOG and AQP4 antibody validation experiments organized by Euroimmun (Luebeck, Germany).
NONE
Euroimmun AG, Germany; Roche, Switzerland
(1) Austrian Science Funds (FWF), project P32699, PI, 2019-2022(2) Austrian Research promotion Agency (FFG), Bridge 1 project Nr. 853209, PI, 2016-2018
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Carsten Finke, MD† and
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Euroimmun AG
(1) German Ministry of Education and Research (BMBF)(2) Deutsche Forschungsgemeinschaft (German Research Foundation, DFG)
(1) Berlin School of Mind and Brain
None
NONE
NONE
NONE
NONE
NONE
NONE
- Kevin Rostásy, MD†
Scientific adviser on Fingolimod project-NovartisScientific adviser Roche/Ocreviusstudy in Children
NONE
Advisory Board Meeting Novartis and Merck 2017, 2018
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (F.B., G.C., C.F.), Charité–Universitätsmedizin Berlin; Berlin Institute of Health at Charité–Universitätsmedizin Berlin (F.B.); Berlin School of Mind and Brain (F.B., C.F.), Humboldt-Universität zu Berlin; Witten/Herdecke University (B.B., Annikki Bertolini, K.R.), Department of Pediatric Neurology, Children's Hospital Datteln; Charité–Universitätsmedizin Berlin (A.A.), Institute of Biometry and Clinical Epidemiology; Department of Pediatric Neurology and Developmental Medicine (Astrid Blaschek), LMU, Dr. von Hauner Children's Hospital, Munich; Department of Pediatric Neurology (E.M.W.), Olgahospital/Klinikum Stuttgart; Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty (M.K.), Heinrich-Heine-University Düsseldorf, Germany; Department of Pediatric I, Pediatric Neurology (M.B.), Medical University of Innsbruck, Austria; Department of Radiology (R.C., A.W.-P.), Children's Hospital Datteln, Witten/Herdecke University, Germany; Department of Pediatrics and Adolescent Medicine (S.L.), Hospital Dritter Orden, Munich, Germany; Department Neuropediatrics (M.S.), Regional Hospital of Bolzano, Italy; Department of Pediatrics (P.K.), Städtisches Klinikum Karlsruhe, Germany; Department of Pediatrics, Brandenburg (T.R.), Helios Klinik Hohenstücken, Germany; and Clinical Department of Neurology (M.R.), Medical University of Innsbruck, Innsbruck, Austria.
- Correspondence
Dr. Rostásy k.rostasy{at}kinderklinik-datteln.de
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.